Home > Financial Ratios > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 5.359.7111.3063.7525.37

What is the latest EV/EBIT ratio of NATCO PHARMA ?

The latest EV/EBIT ratio of NATCO PHARMA is 5.35 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20255.35
Mar20249.71
Mar202311.30
Mar202263.75
Mar202125.37

How is EV/EBIT of NATCO PHARMA Trending?

Years EV/EBIT % Change
Mar2025 5.35
-44.90
Mar2024 9.71
-14.07
Mar2023 11.3
-82.27
Mar2022 63.75
151.28
Mar2021 25.37 -

Other Financial Ratios of NATCO PHARMA


Compare EV/EBIT ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹20,040.4 Cr 1.4% 17% 45.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr 1.2% -7% 2.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 1.8% 2.7% 17% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 0.5% -4.8% 32.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.3% -4.5% 11.5% Stock Analytics
CIPLA ₹100,028.0 Cr 0.7% -5.8% -13.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1.4%

17%

45.6%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses